Resolution 2016-16 - Laserfiche WebLink

Home Browse Search

herein. The City Manager may approve and sign any amendments on behalf of the City that are consistent with the purposes of this Agreement and do not substantially increase the obligations of the City hereunder. 9. NON-DISCRIMINATION. In the performance of this Agreement, the Delegate shall not discriminate against any employee or applicant for employment with regard to race, color, religion, sex, national origin, disability, age, ancestry, or political belief. The Delegate further agrees that no person will be denied equal access to, excluded from participation in, or be denied the proceeds of any CDBG-DR funded project subject to this Agreement, and will adhere to the non-discrimination provisions promulgated pursuant to the Executive Orders and federal statutes referenced in Appendix C. 10. ENFORCEMENT. The City may, for cause and upon giving fifteen (15) days' written notice to the Delegate, undertake one or more of the following courses of action: (A) Withhold funds until the situation has been corrected; (B) Suspend the Delegate's authority to spend funds or to conduct the project until the situation is corrected; or (C) Terminate this Agreement in whole or in part. Cause shall include, but not be limited to: (A) Failure, for any reason, of the Delegate to fulfill in a timely and proper manner its obligations under this Agreement; (B) Submission by the Delegate to HUD, the State, or to the City of reports that are incorrect or incomplete in any material respect; (C) Ineffective or improper use of funds provided under or generated by this Agreement; or (D) Suspension or termination by the State or HUD of the grant to the City under which this Agreement is made, or the portion thereof delegated by this Agreement. Delegate shall comply with the provisions of the Recapture Plan in Appendix G. 11. TERMINATION. (A) Either party may terminate this Agreement without cause upon thirty (30) days' written notice to the other party. 5 L.\FRIEDLAN\My Documents L\CDBG\2016 CDBG-DR IGA Lowsvt le F1NAL.docx 3/15/2016